OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Thomas S. Vedvick is the director of process sciences at the Infections Disease Research Institute, Seattle, WA
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
The HMS174 strain, in the absence or presence of excess phosphate, can metabolize acetate efficiently.